{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:35Z","timestamp":1707524975028},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,5]]},"DOI":"10.7759\/cureus.37175","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T20:50:07Z","timestamp":1680727807000},"source":"Crossref","is-referenced-by-count":0,"title":["Encapsulated Papillary Oncocytic Neoplasm: A Newly Recognized Hurthle Cell Neoplasm With Unique Morphology"],"prefix":"10.7759","author":[{"given":"Noor","family":"Marji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwer","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.008474","article-title":"My approach to oncocytic tumours of the thyroid","volume":"57","author":"Asa SL","year":"2004","unstructured":"Asa SL. My approach to oncocytic tumours of the thyroid. J Clin Pathol. 2004, 57:225-32. 10.1136\/jcp.2003.008474","journal-title":"J Clin Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch ZW","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, et al.. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022, 33:27-63. 10.1007\/s12022-022-09707-3","journal-title":"Endocr Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","article-title":"A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995","volume":"83","author":"Hundahl SA","year":"1998","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer. 1998, 83:2638-48. 10.1002\/(SICI)1097-0142(19981215)83:12&lt;2638::AID-CNCR31&gt;3.0.CO;2-1","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27770","article-title":"Hurthle cell carcinoma: a population-level analysis of 3311 patients","volume":"119","author":"Goffredo P","year":"2013","unstructured":"Goffredo P, Roman SA, Sosa JA. Hurthle cell carcinoma: a population-level analysis of 3311 patients. Cancer. 2013, 119:504-11. 10.1002\/cncr.27770","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21828","article-title":"Multicentric encapsulated papillary oncocytic neoplasm of the thyroid: a case diagnosed by a combined cytological, histological, immunohistochemical, and molecular approach","volume":"40","author":"Bellevicine C","year":"2012","unstructured":"Bellevicine C, Malapelle U, Docimo G, Ciancia G, Mossetti G, Pettinato G, Troncone G. Multicentric encapsulated papillary oncocytic neoplasm of the thyroid: a case diagnosed by a combined cytological, histological, immunohistochemical, and molecular approach. Diagn Cytopathol. 2012, 40:450-4. 10.1002\/dc.21828","journal-title":"Diagn Cytopathol"},{"key":"ref6","article-title":"","year":"2017","unstructured":"WHO Classification of Tumours of Endocrine Organs. Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J (ed). WHO\/IARC Press, France; 2017. https:\/\/www.iarc.who.int\/news-events\/who-classification-of-tumours-of-endocrine-organs\/."},{"key":"ref7","article-title":"H\u00fcrthle-cell neoplasms of the thyroid gland","volume":"25","author":"Flint A","year":"1990","unstructured":"Flint A, Lloyd RV. H\u00fcrthle-cell neoplasms of the thyroid gland. Pathol Annu. 1990, 25:37-52.","journal-title":"Pathol Annu"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/106689690501300105","article-title":"Benign H\u00fcrthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma","volume":"13","author":"Mai KT","year":"2005","unstructured":"Mai KT, Elmontaser G, Perkins DG, Thomas J, Stinson WA. Benign H\u00fcrthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma. Int J Surg Pathol. 2005, 13:37-41. 10.1177\/106689690501300105","journal-title":"Int J Surg Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181f2d820","article-title":"Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases","volume":"34","author":"Woodford RL","year":"2010","unstructured":"Woodford RL, Nikiforov YE, Hunt JL, Bellizzi AM, Zhang X, Mills SE, Stelow EB. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases. Am J Surg Pathol. 2010, 34:1582-90. 10.1097\/PAS.0b013e3181f2d820","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90278-1","article-title":"The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases","volume":"28","author":"Berho M","year":"1997","unstructured":"Berho M, Suster S. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol. 1997, 28:47-53. 10.1016\/S0046-8177(97)90278-1","journal-title":"Hum Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800705","article-title":"Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining","volume":"19","author":"Nasr MR","year":"2006","unstructured":"Nasr MR, Mukhopadhyay S, Zhang S, Katzenstein AL. Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining. Mod Pathol. 2006, 19:1631-7. 10.1038\/modpathol.3800705","journal-title":"Mod Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207980","article-title":"Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer","volume":"23","author":"Frattini M","year":"2004","unstructured":"Frattini M, Ferrario C, Bressan P, et al.. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene. 2004, 23:7436-40. 10.1038\/sj.onc.1207980","journal-title":"Oncogene"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/139040-encapsulated-papillary-oncocytic-neoplasm-a-newly-recognized-hurthle-cell-neoplasm-with-unique-morphology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:44Z","timestamp":1707508664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/139040-encapsulated-papillary-oncocytic-neoplasm-a-newly-recognized-hurthle-cell-neoplasm-with-unique-morphology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.37175","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,5]]}}}